<DOC>
	<DOC>NCT00254813</DOC>
	<brief_summary>The purpose of this study is to evaluate the safety and tolerability of a more rapid dose titration in acute schizophrenic patients compared to the conventional titration.</brief_summary>
	<brief_title>Fast Titration Of Quetiapine Versus Currently Approved Titration</brief_title>
	<detailed_description />
	<mesh_term>Psychotic Disorders</mesh_term>
	<mesh_term>Mental Disorders</mesh_term>
	<mesh_term>Quetiapine Fumarate</mesh_term>
	<criteria>Signed informed consent, male or female between 18 and 60 years old, having acute exacerbation of their schizophrenia or schizoaffective disorder requiring admission to hospital. Should stay in hospital for at least 7 days. Patients treated with Risperdal consta or Clozapine last 28 days, pregnancy or breastfeeding, patients known to be intolerant or unresponsive to quetiapine, known arrhythmia, other serious medical conditions.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>January 2011</verification_date>
	<keyword>Schizophrenia</keyword>
	<keyword>Schizoaffective disorder</keyword>
</DOC>